CancerWorld

What does it take to change the odds in cancer care? Innovation? Yes. But also: persistence. Collaboration. The refusal to accept that some lives matter less because of where they’re born. In this issue of CancerWorld, we focus not just…

I grew up around a lot of physicians,” begins Adrian Gottschalk, President and CEO of Foghorn Therapeutics, a biotech company redefining how we understand and treat complex diseases by targeting the chromatin regulatory system. “My late father was a professor…

The People Behind the Progress in Oncology is science. But it is also stories. It is policy. It is power. It is knowledge. It is culture. It is trust. And above all, it’s personal. This is the lens through which…